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Tick-borne Encephalitis in Professionally Exposed Persons 
after Complete Primary Vaccination
Krpeljni encefalitis kod profesionalno izložene osobe 
nakon uredno provedenog primarnog cijepljenja
Abstract
In this paper we present a case report of tick-borne encephalitis (TBE) in a pro-
fessionally exposed person (forestry worker) who acquired this infection three 
years after he had received a complete primary vaccination. The patient report-
ed multiple tick bites, the last one eighteen days prior to disease onset. The 
TBE diagnosis was confirmed according to the European Center for Disease 
Prevention and Control case definition of TBE by clinical criteria (meningitis), 
epidemiological link (exposure to tick bites in an endemic area) and laboratory 
criteria (detection of TBEV specific IgM and IgG antibodies in CSF and serum 
samples). The case presented indicates the need of awareness of possible TBE 
even in persons who have received complete vaccination, especially in the pro-
fessionally exposed ones or those exposed to multiple tick bites.
Sažetak
U radu prikazujemo slučaj krpeljnog encefalitisa (KE) kod profesionalno 
izložene osobe (šumar) koja je oboljela tri godine nakon uredno provedenog 
primarnog cijepljenja. Pacijent je naveo višestruke ugrize krpelja, od kojih je 
posljednji bio osamnaest dana prije početka bolesti. Dijagnoza KE potvrđena 
je prema kriterijima Europskog centra za kontrolu bolesti (ECDC) na temelju 
kliničkih (meningitis), epidemioloških (izloženost krpeljima u endemskom po-
dručju) te laboratorijskih kriterija (dokaz specifičnih IgM i IgG protutijela za 
KE u uzorcima seruma i cerebrospinalnog likvora). Prikazani slučaj naglašava 
potrebu za promišljanjem o mogućoj pojavi KE i kod osoba kod kojih je pro-
vedeno kompletno cijepljenje, osobito profesionalno izloženih osoba te onih 
izloženih čestim ugrizima krpelja.
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Introduction
 Tick-borne encephalitis (TBE) is an emerging zoon-
osis caused by the tick-borne encephalitis virus (TBEV). 
The TBE is one of the most important diseases of the cen-
tral nervous system in many European countries with an 
increasing incidence over the past few decades. In Europe 
and Asia, between 10,000 and 15,000 TBE cases are re-
ported annually. Most cases of TBE occur during the high-
est period of ticks activity in Central Europe, mainly from 
April to November [1]. In addition to tick bite, the disease 
can also be transmitted through consumption of unpas-
teurized milk or dairy products from infected livestock 
[2]. There is a broad range of severity grade of TBEV 
infection, ranging from an asymptomatic infection to a 
severe meningoencephalomyelitis. In European countries, 
TBE presents as meningitis in about 50% of patients, as 
meningoencephalitis in 40%, and as meningoencephalo-
myelitis in 10% [3]. Although the disease can be efficient-
ly prevented by active immunization, vaccination failures 
have been described, especially in elderly people [4-6].
 In Croatia, TBE is endemic in north western regions, 
but infections are reported in all continental counties with 
an average of 36 (range 11-87) cases registered on annu-
al basis [7]. Vaccination against TBEV is not mandato-
ry in Croatia, but is recommended to persons exposed to 
TBE risk, such as forestry workers and hunters or those 
frequently visiting the forests and grasslands where ticks 
populations are high. We present the case of TBE in a 
young professionally exposed person who has received a 
complete primary vaccination.
Case report
 In May 2017, a 36-year-old man, forestry worker, was 
hospitalized at the Clinic for Infectious Diseases on the 
sixth day of the illnesses. The disease was manifested by 
daily fever up to 40°C, headache, nausea, diarrhoea and 
vomiting. The patient reported multiple tick bites, the 
last one 18 days prior to disease onset (Gorski Kotar). 
In 2013/2014, he received a complete primary vaccina-
tion with three doses of TBEV vaccine (the last one in 
April 2014). At the moment of the admission, the patient 
was febrile (38°C), oriented, and mildly dehydrated. The 
physical and neurological examination indicated no prob-
lems, except the neck stiffness. The patient was initially 
treated with acyclovir (until the completion of virology 
results) with a supportive (antiedematous) therapy. From 
the fourth day of hospitalization, the patient was afebrile 
and without a headache. The patient was monitored during 
the four months and he has fully recovered.
Laboratory and Neuroimaging Results
 Routine laboratory tests (Table 1) indicated an ele-
vated white blood cell (WBC) count (14.1x109/L). The 
patient’s C-reactive protein level amounted to 14.4 mg/L, 
and his erythrocyte sedimentation rate to 23 mm/h. Other 
laboratory parameters were within normal range. Cere-
brospinal fluid (CSF) analysis revealed a WBC count of 
132x106/L (76% lymphocytes), protein level of 0.753 g/L 
and glucose level of 3.61 mmol/L. Electroencephalogram 
(EEG) indicated slow diffuse dysrhythmia and computed 
tomography of the brain was normal. Normalization of 
EEG finding occurred after four months from initial eval-
uation.
Virology Results
 CSF, serum and urine samples were collected and 
tested for the presence of TBEV antibodies and/or TBEV 
RNA. TBEV IgM/IgG antibodies and IgG avidity were 
detected using enzyme-linked immunosorbent assays 
(ELISA; Euroimmun, Lübeck, Germany). To exclude 
cross-reactivity with other flaviviruses, serum and CSF 
samples were also tested for West Nile virus (WNV) and 
Usutu virus (USUV) antibodies. TBEV RNA was detect-
ed using a real-time RT-PCR according to the protocol of 
Schwaiger et al. [8], WNV RNA according to the protocol 
of Tang et al. [9] and USUV RNA according to the proto-
col of Nikolay et al. [10].
 Virology results are presented in the Table 2. Although 
cross-reactive antibodies with WNV and USUV were de-
tected in serology tests, very high values of TBEV IgM 
and IgG antibodies in both serum (IgM ratio 5.01; IgG 
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Table 1. Laboratory findings in patient with tick-borne encephalitis
Tablica 1. Laboratorijski nalazi u bolesnika s krpeljnim meningoencefalitisom
Parameter Value Reference values
BLOOD
 White blood cells; WBC (x109/L)
 Red blood cells; RBC (x1012/L)
 Hemoglobin (g/L)
 C-reactive protein (mg/L)
 Erythrocyte sedimentation rate
 Aspartate-aminotransferase; AST (U/L)
 Alanine-aminotransferase; ALT (U/L)
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a booster dose thereafter. He was continuously exposed 
to multiple tick bites (professional exposure) and devel-
oped symptoms of TBE at the beginning of May 2017, 
36 months upon the last vaccination. Similar results were 
observed in a Slovenian study, i.e. the median time inter-
val between the last dose of TBE vaccine and illness onset 
was 36 (1-180) months [11].
 Due to different and sometimes confusing antibody 
kinetics in vaccinated patients with TBEV infection, these 
infections may be overlooked [13]. It is well known that 
TBE patients have detectable serum IgM antibodies and 
the vast majority of them also has IgG antibodies at the 
beginning of the neurologic phase of the disease [11, 14]. 
In contrast, patients who develop TBE breakthrough, gen-
erally have very high TBEV IgG antibody levels, while 
IgM antibody response may be absent or low in the first 
days of the meningoencephalitic phase [11, 15]. In addi-
tion, TBEV IgG antibodies are of high avidity in vacci-
nated persons [11]. According to the European Center for 
Disease Prevention and Control case definition of TBE, 
the diagnosis of TBE in our patient was established by 
clinical criteria (symptoms of meningitis), epidemiologi-
cal link (exposure to tick bite in an endemic area) and lab-
oratory criteria for a confirmed case (detection of TBEV 
specific IgM and IgG antibodies in both CSF and serum) 
[16]. Since the patient was vaccinated against TBE, IgG 
antibodies were at very high level and showed high avidi-
ty. TBEV RNA was not detected in CSF and urine samples.
 The case presented in this report indicates the need 
of awareness of possible TBE, even in completely vac-
>200 RU/ml) and CSF (IgM ratio 4.35; IgG 191 RU/ml) 
at the initial testing indicate a TBEV infection. In addition, 
TBE was further supported by antibody dynamics, i.e. a 
decline of IgM antibodies in the two consecutive serum 
samples (ratio 4.20 and 2.82, respectively) with continu-
ously very high IgG levels (>200 RU/ml). Since the pa-
tient was vaccinated against TBEV, IgG avidity was high 
(98%). TBEV, WNV and USUV RNA was not detected in 
CSF and urine samples. CSF sample was additionally test-
ed for the presence of other neuroinvasive viruses: herpes 
simplex viruses 1/2, enteroviruses, Toscana virus, Tahyna 
virus and lymphocytic choriomeningitis virus using PCR 
or RT-PCR. All the results were negative. PCR and serol-
ogy for Borrelia burgdorferi were also negative.
Discussion
 Although TBEV vaccine failure is rare, in particular 
after completed vaccination, there are several reports of 
TBEV infection in incompletely and completely vaccinat-
ed persons. A recently published study from Slovenia, an 
endemic country for TBE, reported that 1.7% of vacci-
nated persons have developed TBE, 64.1% of whom had 
received complete basic vaccination and the others had re-
ceived only two doses prior to disease onset. In addition, 
the acute illness in patients with TBE breakthrough was 
shown to be more severe than in unvaccinated persons 
[11]. Moreover, there are few reports of a fatal outcome of 
TBE in vaccinated persons [12].
 The patient presented in this report received the last 























Table 2. Virology results in patient with tick-borne encephalitis























































*ratio <0.8 negative; 0.8-1.1 borderline; >1.1 positive
**RU/ml <16 negative; 16-22 borderline; >22 positive
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cinated persons, especially in those exposed to multiple 
tick bites [7]. Therefore, TBE should remain an important 
differential diagnosis in these patients. In addition, clini-
cians should keep in mind that the presence of TBEV IgG 
antibodies in the absence of IgM antibodies at the onset 
of clinical symptoms does not exclude TBE in previously 
vaccinated patients [12].
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